Drug Profile
Cefepime oral - Nexgen Biosciences
Alternative Names: NB-8947Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Nexgen Biosciences
- Class Anti-infectives; Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Bacterial infections
Most Recent Events
- 05 Aug 2016 Investigation in Bacterial infections in USA (PO)